Ukhyun Jo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Dna Damage Response

Top Venues

Cancer research communications

Molecular cancer therapeutics

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yashuhiro Arakawa, Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas, Nitin Roper, Diana Grace Varghese, Naoko Takebe, Xiaohu Zhang, Michele Ceribelli, David O Holland, Eric Beck, Zina Itkin, Crystal McKnight, Kelli M Wilson, Jameson Travers, Carleen Klump-Thomas, Craig J Thomas, Chuong D Hoang, Jonathan M Hernandez, Jaydira Del Rivero, Yves Pommier
Activity of the ubiquitin-activating enzyme inhibitor TAK-243 in adrenocortical carcinoma (ACC) cell lines, patient-derived organoids (PDOs) and murine xenografts. Cancer research communications (2024)
Yashuhiro Arakawa, Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas, Nitin Roper, Diana Grace Varghese, Naoko Takebe, Xiaohu Zhang, Michele Ceribelli, David O Holland, Eric Beck, Zina Itkin, Crystal McKnight, Kelli M Wilson, Jameson Travers, Carleen Klump-Thomas, Craig J Thomas, Chuong D Hoang, Jonathan M Hernandez, Jaydira Del Rivero, Yves Pommier
Activity of the ubiquitin-activating enzyme inhibitor TAK-243 in adrenocortical carcinoma (ACC) cell lines, patient-derived organoids (PDOs) and murine xenografts. Cancer research communications (2024)
Yashuhiro Arakawa, Fathi Elloumi, Sudhir Varma, Prashant Khandagale, Ukhyun Jo, Suresh Kumar, Nitin Roper, William C Reinhold, Robert W Robey, Naoko Takebe, Michael M Gottesman, Craig J Thomas, Valentina Boeva, Alfredo Berruti, Andrea Abate, Mariangela Tamburello, Sandra Sigala, Constanze Hantel, Isabel Weigand, Margaret E Wierman, Katja Kiseljak-Vassiliades, Jaydira Del Rivero, Yves Pommier
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples. Cancer research communications (2024)
Yashuhiro Arakawa, Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas, Nitin Roper, Diana Grace Varghese, Naoko Takebe, Xiaohu Zhang, Michele Ceribelli, David O Holland, Eric Beck, Zina Itkin, Crystal McKnight, Kelli M Wilson, Jameson Travers, Carleen Klump-Thomas, Craig J Thomas, Chuong D Hoang, Jonathan M Hernandez, Jaydira Del Rivero, Yves Pommier
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts. Cancer research communications 4 (3) (2024)
Ukhyun Jo, Yashuhiro Arakawa, Astrid Zimmermann, Daiki Taniyama, Makito Mizunuma, Lisa M Miller Jenkins, Tapan Maity, Suresh Kumar, Frank T Zenke, Naoko Takebe, Yves Pommier
The novel ATR inhibitor M1774 induces replication protein overexpression and broad synergy with DNA-targeted anticancer drugs. Molecular cancer therapeutics (2024)
Ukhyun Jo, Yashuhiro Arakawa, Astrid Zimmermann, Daiki Taniyama, Makito Mizunuma, Lisa M Miller Jenkins, Tapan Maity, Suresh Kumar, Frank T Zenke, Naoko Takebe, Yves Pommier
The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs. Molecular cancer therapeutics 23 (7) (2024)
Yashuhiro Arakawa, Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas, Nitin Roper, Diana Grace Varghese, Naoko Takebe, Xiaohu Zhang, Michele Ceribelli, David O Holland, Eric Beck, Zina Itkin, Crystal McKnight, Kelli M Wilson, Jameson Travers, Carleen Klump-Thomas, Craig J Thomas, Chuong D Hoang, Jonathan M Hernandez, Jaydira Del Rivero, Yves Pommier
Activity of the ubiquitin-activating enzyme inhibitor TAK-243 in adrenocortical carcinoma (ACC) cell lines, patient-derived organoids (PDOs) and murine xenografts. Cancer research communications (2024)
Junko Murai, Michele Ceribelli, Haiqing Fu, Christophe E Redon, Ukhyun Jo, Yasuhisa Murai, Mirit I Aladjem, Craig J Thomas, Yves Pommier
Schlafen 11 (SLFN11) kills cancer cells undergoing unscheduled re-replication. Molecular cancer therapeutics (2023)
Ukhyun Jo, Yasuhisa Murai, Keli K Agama, Yilun Sun, Liton Kumar Saha, Xi Yang, Yasuhiro Arakawa, Sophia Gayle, Kelli Jones, Vishwas Paralkar, Ranjini K Sundaram, Jinny Van Doorn, Juan C Vasquez, Ranjit S Bindra, Woo Suk Choi, Yves Pommier
TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular cancer therapeutics 21 (7) (2022)
Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W Schultz, Anish Thomas, Frank T Zenke, Yves Pommier
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents. Molecular cancer therapeutics 20 (8) (2021)
Yasuhisa Murai, Ukhyun Jo, Junko Murai, Lisa M Miller Jenkins, Shar-Yin N Huang, Sirisha Chakka, Lu Chen, Ken Cheng, Shinsaku Fukuda, Naoko Takebe, Yves Pommier
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243. Cancer research 81 (11) (2021)